Literature DB >> 26297556

Closing the tau loop: the missing tau mutation.

Allan McCarthy1, Roisin Lonergan1, Diana A Olszewska1, Sean O'Dowd1, Gemma Cummins2, Brian Magennis1, Emer M Fallon1, Niall Pender3, Edward D Huey4, Stephanie Cosentino5, Killian O'Rourke1, Brendan D Kelly6, Martin O'Connell7, Isabelle Delon8, Michael Farrell9, Maria Grazia Spillantini10, Lewis P Rowland11, Stanley Fahn11, Peter Craig12, Michael Hutton12, Tim Lynch13.   

Abstract

Frontotemporal lobar degeneration comprises a group of disorders characterized by behavioural, executive, language impairment and sometimes features of parkinsonism and motor neuron disease. In 1994 we described an Irish-American family with frontotemporal dementia linked to chromosome 17 associated with extensive tau pathology. We named this disinhibition-dementia-parkinsonism-amyotrophy complex. We subsequently identified mutations in the MAPT gene. Eleven MAPT gene splice site stem loop mutations were identified over time except for 5' splice site of exon 10. We recently identified another Irish family with autosomal dominant early amnesia and behavioural change or parkinsonism associated with the 'missing' +15 mutation at the intronic boundary of exon 10. We performed a clinical, neuropsychological and neuroimaging study on the proband and four siblings, including two affected siblings. We sequenced MAPT and performed segregation analysis. We looked for a biological effect of the tau variant by performing real-time polymerase chain reaction analysis of RNA extracted from human embryonic kidney cells transfected with exon trapping constructs. We found a c.915+15A>C exon 10/intron 10 stem loop mutation in all affected subjects but not in the unaffected. The c.915+15A>C variant caused a shift in tau splicing pattern to a predominantly exon 10+ pattern presumably resulting in predominant 4 repeat tau and little 3 repeat tau. This strongly suggests that the c.915+15A>C variant is a mutation and that it causes frontotemporal dementia linked to chromosome 17 in this pedigree by shifting tau transcription and translation to +4 repeat tau. Tau (MAPT) screening should be considered in families where amnesia or atypical parkinsonism coexists with behavioural disturbance early in the disease process. We describe the final missing stem loop tau mutation predicted 15 years ago. Mutations have now been identified at all predicted sites within the 'stem' when the stem-loop model was first proposed and no mutations have been found within the 'loop' region as expected. Therefore we 'close the tau loop' having 'opened the loop' 21 years ago.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  FTDP-17; MAPT; dementia; frontotemporal; stem loop

Mesh:

Substances:

Year:  2015        PMID: 26297556      PMCID: PMC5006396          DOI: 10.1093/brain/awv234

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  44 in total

Review 1.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

2.  Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene.

Authors:  S M Pickering-Brown; A M T Richardson; J S Snowden; A M McDonagh; A Burns; W Braude; M Baker; W-K Liu; S-H Yen; J Hardy; M Hutton; Y Davies; D Allsop; D Craufurd; D Neary; D M A Mann
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

3.  Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.

Authors:  P Nacharaju; J Lewis; C Easson; S Yen; J Hackett; M Hutton; S H Yen
Journal:  FEBS Lett       Date:  1999-03-26       Impact factor: 4.124

4.  Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.

Authors:  T Lynch; M Sano; K S Marder; K L Bell; N L Foster; R F Defendini; A A Sima; C Keohane; T G Nygaard; S Fahn
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

5.  Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia.

Authors:  Gregory A Rippon; Richard Crook; Matthew Baker; Elizabeth Halvorsen; Steven Chin; Michael Hutton; Henry Houlden; John Hardy; Timothy Lynch
Journal:  Arch Neurol       Date:  2003-06

6.  Interaction of tau protein with the dynactin complex.

Authors:  Enrico Magnani; Juan Fan; Laura Gasparini; Matthew Golding; Meredith Williams; Giampietro Schiavo; Michel Goedert; Linda A Amos; Maria Grazia Spillantini
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

7.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

Review 8.  Phenotypic signatures of genetic frontotemporal dementia.

Authors:  Jonathan D Rohrer; Jason D Warren
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

9.  Neuropathologic variation in frontotemporal dementia due to the intronic tau 10(+16) mutation.

Authors:  P L Lantos; N J Cairns; M N Khan; A King; T Revesz; J C Janssen; H Morris; M N Rossor
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

10.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

View more
  18 in total

Review 1.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

Review 2.  Genetics of Frontotemporal Dementia.

Authors:  Diana A Olszewska; Roisin Lonergan; Emer M Fallon; Tim Lynch
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

Review 3.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

4.  The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital.

Authors:  Diana A Olszewska; Terri McVeigh; Emer M Fallon; Gregory M Pastores; Tim Lynch
Journal:  Ir J Med Sci       Date:  2018-03-09       Impact factor: 1.568

5.  Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers.

Authors:  Gayathri Cheran; Hannah Silverman; Masood Manoochehri; Jill Goldman; Seonjoo Lee; Liwen Wu; Sarah Cines; Emer Fallon; Brendan Desmond Kelly; Diana Angelika Olszewska; Judith Heidebrink; Sarah Shair; Stephen Campbell; Henry Paulson; Timothy Lynch; Stephanie Cosentino; Edward D Huey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

6.  Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT Variants.

Authors:  Laura Williams; Diana A Olszewska; Conor Fearon; Brian Magennis; Allan McCarthy; Lewis P Rowland; Richard Mayeux; Rory Page; Stanley Fahn; Alan Beausang; Tim Lynch
Journal:  Mov Disord Clin Pract       Date:  2021-06-24

Review 7.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

Review 8.  Microtubule Destabilization Paves the Way to Parkinson's Disease.

Authors:  D Cartelli; G Cappelletti
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

9.  Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers.

Authors:  Gayathri Cheran; Liwen Wu; Seonjoo Lee; Masood Manoochehri; Sarah Cines; Emer Fallon; Timothy Lynch; Judith Heidebrink; Henry Paulson; Jill Goldman; Edward Huey; Stephanie Cosentino
Journal:  J Int Neuropsychol Soc       Date:  2018-11-21       Impact factor: 2.892

10.  In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.

Authors:  David T Jones; David S Knopman; Jonathan Graff-Radford; Jeremy A Syrjanen; Matthew L Senjem; Christopher G Schwarz; Christina Dheel; Zbigniew Wszolek; Rosa Rademakers; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Bradley F Boeve
Journal:  Neurology       Date:  2018-02-09       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.